# V1 Empirics Check — openai/gpt-oss-120b (Variant A)

**Model:** openai/gpt-oss-120b
**Variant:** A
**Date:** 2026-04-02T00:14:11.150791

---

**1. Idea Fidelity**  

The manuscript follows the manifest closely. It tackles the exact question posed in the idea sheet – how the staggered adoption of Differential Response (DR) creates a mechanical drop in NCANDS‑reported substantiated victim counts – and it uses the same data sources (Kids Count, ACF child‑maltreatment reports, Census population estimates). The identification strategy outlined in the manifest (a staggered “CS‑DiD” with Callaway‑Sant’Anna aggregation, denominator decomposition, and falsification using child‑fatality data) is implemented in the paper. The only notable deviation is that the empirical section drops the 1993‑2001 early‑adopter states from the Callaway‑Sant’Anna panel (because the panel starts in 2004), whereas the manifest suggested a full‑sample CS‑DiD. This is a reasonable compromise given data availability, but it should be acknowledged as a departure from the original plan.

**2. Summary**  

The paper estimates the causal impact of state‑level adoption of Differential Response on the number of substantiated child‑maltreatment victims reported in NCANDS. Using a staggered difference‑in‑differences design with Callaway‑Sant’Anna estimators, the author finds that DR reduces measured victim rates by roughly 0.25 per 1,000 children (≈ ‑0.09 standard deviations), while referral volumes remain flat and child‑fatality rates rise, suggesting the observed national decline in maltreatment statistics is largely a measurement artifact.

**3. Essential Points**  

1. **Statistical Power and Precision** – The central point estimate is economically meaningful but statistically indistinguishable from zero (SE ≈ 0.43). The paper repeatedly claims “the evidence is compelling” without a clear discussion of power. With only 32 treated states and modest treatment heterogeneity, the study is under‑powered to detect the modest effect size implied by the mechanism. The authors must either provide a formal power calculation or temper their claims accordingly.

2. **Parallel‑Trends Validation** – The event‑study (Table 3) shows noisy pre‑treatment coefficients; the confidence intervals are wide and include sizable deviations from zero. Moreover, the earliest pre‑treatment periods (‑5, ‑4) have point estimates of –0.5 and –0.2 per 1,000, which, while not statistically significant, are not negligible. The manuscript should bolster the parallel‑trends argument, for example by (i) showing graphical event‑study plots with confidence bands, (ii) restricting the sample to cohorts with longer pre‑treatment windows, or (iii) adding covariates (e.g., welfare spending, unemployment) that could absorb differential trends.

3. **Measurement of the “Treatment”** – DR adoption is coded as a binary indicator that switches on in the first calendar year a state legislates DR. In reality, implementation is gradual: many states start with pilot counties, expand over several years, and vary the share of referrals diverted. Treating DR as a one‑off binary switch may bias the estimate towards zero (attenuation) and also raises concerns about omitted‑variable bias if early implementation correlates with other reforms. The authors should (a) discuss this limitation explicitly, (b) consider using a continuous “intensity” measure (e.g., share of referrals diverted, if available from state reports), or (c) conduct sensitivity analyses assuming delayed implementation.

**4. Suggestions**  

*Methodological Strengthening*  

- **Power Analysis**: Include a Monte‑Carlo or analytic power calculation showing the minimum detectable effect given the observed variance, number of treated states, and intra‑state correlation. This will help readers judge whether the null result is due to lack of effect or insufficient data.

- **Robust Parallel‑Trends Checks**: Present graphical event‑study panels with 95 % confidence intervals for each cohort, not just the pooled ATT. If any cohort shows pre‑trend violations, consider estimating cohort‑specific DiDs or dropping problematic cohorts.

- **Alternative Controls**: The set of “never‑treated” states includes a mix of high‑ and low‑screening states. To rule out that the observed effect is driven by systematic differences (e.g., states that never adopt DR may have higher baseline screening rates), construct a propensity‑score‑matched control group based on pre‑treatment characteristics (screening rate, welfare generosity, baseline victim rate, demographic composition). Report the ATT on this matched sample.

- **Dynamic Treatment Effects**: The current event‑study collapses all cohorts into a single ATT. Because the mechanism predicts that the reclassification effect grows as the assessment track is scaled up, report cohort‑specific dynamic ATT curves (early vs. late adopters). This will illustrate whether the post‑adoption decline indeed deepens over time.

- **Falsification Using Non‑DR‑Sensitive Outcomes**: The child‑fatality test is compelling, but adding another outcome that should be unaffected, such as juvenile court filings for non‑violent offenses or school‑attendance rates, would further bolster the claim that only the measurement channel is altered.

- **Placebo Policy Tests**: Randomly assign “pseudo‑DR” dates to a subset of never‑treated states and run the full CS‑DiD. Show the distribution of placebo ATT’s alongside the actual estimate to demonstrate that the observed magnitude is unusual.

*Data and Variable Improvements*  

- **Refine the Treatment Variable**: Where possible, incorporate state‑level data on the proportion of referrals funneled into the assessment track (some states publish annual “assessment” counts). Even a rough indicator (e.g., “assessment track established” vs. “full DR”) could be used to construct a dose‑response specification.

- **Include Screening Rates as a Moderator**: Since the reclassification can only operate on screened‑in referrals, interact DR adoption with the state‑level screening rate. Expect larger negative effects in states with high screening rates, providing a test of the mechanism.

- **Address Potential Confounders**: Several states adopted DR contemporaneously with other child‑welfare reforms (e.g., changes to the “Family First” prevention budget, adoption of the “Child First” model). Assemble a timeline of major policy changes and include them as controls or conduct an event‑study that excludes overlapping reforms.

*Presentation and Interpretation*  

- **Clarify the “Measurement Artifact” Narrative**: The paper sometimes mixes the descriptive claim (“the national decline is largely an illusion”) with the causal estimate (“DR reduces victim rates by 0.25 per 1,000”). Emphasize that the causal estimate is a lower‑bound on the artifact because only the portion of low‑risk referrals diverted is captured; the true magnitude may be larger.

- **Re‑frame the Standardized Effect Size**: A SDE of –0.09 is modest. Rather than labeling it “moderate,” compare it to familiar benchmarks (e.g., the effect of a major policy reform on health outcomes) to convey its practical significance.

- **Expand the Discussion of External Validity**: While the focus is on U.S. CPS systems, many countries have analogous “alternative response” models. Briefly discuss how the findings might translate internationally, and what data‑availability issues arise.

- **Appendix Enhancements**: Include (i) the full list of DR adoption dates with sources, (ii) robustness tables for alternative specifications (e.g., with state‑specific trends, logarithmic outcomes, and year‑fixed effects only), and (iii) the exact code for generating the Callaway‑Sant’Anna weights (to aid reproducibility).

*Minor Corrections*  

- Table 1’s “Panel B” reports post‑DR means that are higher than pre‑DR means for DR states; this contradicts the narrative that victim rates fall after adoption. Verify whether the columns refer to “post‑treatment” period averages across all years after adoption or simply the next calendar year.

- In the abstract the phrase “standardized effect: $‑0.09$” should be accompanied by a note that it is statistically insignificant.

- Cite the most recent literature on measurement error in administrative data (e.g., recent AER‑Insights papers on police reform, COVID‑19 testing) to situate the contribution.

- Throughout, ensure that “victim” always refers to the NCANDS‑recorded substantiated child, and avoid ambiguous shorthand that could be confused with “referral” or “assessment.”

*Overall Assessment*  

The paper tackles an important and largely overlooked source of bias in child‑welfare research. The research question is well motivated, the data are publicly available, and the identification strategy (staggered DiD with Callaway‑Sant’Anna) is appropriate. However, the current version overstates the strength of the evidence given the imprecise estimates and modest pre‑trend validation. Addressing the three essential points above—power, parallel trends, and treatment measurement—and incorporating the suggested robustness checks will markedly improve the credibility of the findings. With those revisions, the manuscript would make a valuable AER‑Insights contribution.
